SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-18-000125
Filing Date
2018-12-04
Accepted
2018-12-04 16:47:23
Documents
6
Period of Report
2018-12-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-form8xkkimappointment.htm 8-K 41523
2 EXHIBIT 10.1 ex101sesenbio-dkimemployme.htm EX-10.1 65457
3 EXHIBIT 10.2 sesn-exhibit102indemnifica.htm EX-10.2 119129
4 EXHIBIT 99.1 ex991sesn-cmoreleasedraft2.htm EX-99.1 13748
5 sesenbiodkimemploymen_image1.gif GRAPHIC 6444
6 sesncmoreleasedraft20_image1.jpg GRAPHIC 200325
  Complete submission text file 0001485003-18-000125.txt   513622
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 181217402
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1